Aspire Biopharma Holdings Inc.

08/19/2026 | Press release | Distributed by Public on 08/19/2026 06:30

Regulation FD Presentation (Form 8-K)

Aspire Biopharma Holdings Inc. published this content on August 19, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 19, 2026 at 12:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]